Partner with us to discover
new frontiers in drug development

We are looking forward to creating great partnership with your company. Join our mission to discover the next breakthrough medicine.
Together, we can make a difference in the world of medicine.

Out-licensing of
oncology programs

• Four small molecule Immuno-oncology assets in pre-clinical stage
• Out-licensing or spin-off opportunities being sought
• Global Territory except KR

Early stage
R&D collaboration

• Platform-based collaboration rather than asset-base
• ADC, PROTAC, and gene therapies
• Focus on oncology & immunology
• Global territory except KR

In-licensing of
late stage assets

• Assets in Phase 3 or later
• Focus on Endo, GI and Muscular skeletal
• Korea territory